IT1178911B - Dispositivo osmotico avente duplice attivita termodinamica per la erogazione a velocita controllata di una sostanza particolarmente un farmaco all ambiente a cui e destinata - Google Patents

Dispositivo osmotico avente duplice attivita termodinamica per la erogazione a velocita controllata di una sostanza particolarmente un farmaco all ambiente a cui e destinata

Info

Publication number
IT1178911B
IT1178911B IT8467283A IT6728384A IT1178911B IT 1178911 B IT1178911 B IT 1178911B IT 8467283 A IT8467283 A IT 8467283A IT 6728384 A IT6728384 A IT 6728384A IT 1178911 B IT1178911 B IT 1178911B
Authority
IT
Italy
Prior art keywords
drug
substance
environment
intended
controlled speed
Prior art date
Application number
IT8467283A
Other languages
English (en)
Italian (it)
Other versions
IT8467283A1 (it
IT8467283A0 (it
Inventor
Patrick S L Wong
Brian Barclay
Joseph C Deters
Felix Theeuwes
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23961585&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IT1178911(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alza Corp filed Critical Alza Corp
Publication of IT8467283A0 publication Critical patent/IT8467283A0/it
Publication of IT8467283A1 publication Critical patent/IT8467283A1/it
Application granted granted Critical
Publication of IT1178911B publication Critical patent/IT1178911B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • External Artificial Organs (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
IT8467283A 1983-05-11 1984-03-23 Dispositivo osmotico avente duplice attivita termodinamica per la erogazione a velocita controllata di una sostanza particolarmente un farmaco all ambiente a cui e destinata IT1178911B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49376083A 1983-05-11 1983-05-11

Publications (3)

Publication Number Publication Date
IT8467283A0 IT8467283A0 (it) 1984-03-23
IT8467283A1 IT8467283A1 (it) 1985-09-23
IT1178911B true IT1178911B (it) 1987-09-16

Family

ID=23961585

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8467283A IT1178911B (it) 1983-05-11 1984-03-23 Dispositivo osmotico avente duplice attivita termodinamica per la erogazione a velocita controllata di una sostanza particolarmente un farmaco all ambiente a cui e destinata

Country Status (20)

Country Link
JP (1) JPS6041609A (enrdf_load_stackoverflow)
AT (1) AT397180B (enrdf_load_stackoverflow)
AU (1) AU566110B2 (enrdf_load_stackoverflow)
BE (1) BE898819A (enrdf_load_stackoverflow)
CA (1) CA1222950A (enrdf_load_stackoverflow)
CH (1) CH669329A5 (enrdf_load_stackoverflow)
DE (1) DE3417113A1 (enrdf_load_stackoverflow)
DK (1) DK163910C (enrdf_load_stackoverflow)
ES (1) ES532018A0 (enrdf_load_stackoverflow)
FR (1) FR2545721B1 (enrdf_load_stackoverflow)
GB (1) GB2140687B (enrdf_load_stackoverflow)
IE (1) IE56515B1 (enrdf_load_stackoverflow)
IL (1) IL71727A (enrdf_load_stackoverflow)
IT (1) IT1178911B (enrdf_load_stackoverflow)
MX (1) MX163518B (enrdf_load_stackoverflow)
NL (1) NL192250C (enrdf_load_stackoverflow)
NO (1) NO170834C (enrdf_load_stackoverflow)
NZ (1) NZ206600A (enrdf_load_stackoverflow)
SE (1) SE455918B (enrdf_load_stackoverflow)
ZA (1) ZA842422B (enrdf_load_stackoverflow)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH075457B2 (ja) * 1983-08-16 1995-01-25 ザ ウエルカム フアウンデ−シヨン リミテツド 調節された方法による有効成分の放出を可能にする医薬組成物
US4600773A (en) * 1983-12-01 1986-07-15 Eli Lilly And Company Crystalline cephalexin hydrochloride monohydrate
US4624847A (en) * 1985-04-22 1986-11-25 Alza Corporation Drug delivery device for programmed delivery of beneficial drug
US4963141A (en) * 1985-08-16 1990-10-16 Alza Corporation Dispensing system for administering beneficial agent formulation to ruminants
ES8800043A1 (es) * 1985-08-16 1987-10-16 Alza Corp Un dispositivo distribuidor para descargar una formulacion de agente beneficioso a un entorno de uso
US4704118A (en) * 1985-08-16 1987-11-03 Alza Corporation Ruminant dispensing device with thermo-activated memory
US4723957A (en) * 1986-02-07 1988-02-09 Alza Corp. System for delivering drug with enhanced bioacceptability
US4716496A (en) * 1986-05-09 1987-12-29 Eaton Corporation Panel-mounted control station housing
US4814181A (en) * 1987-09-03 1989-03-21 Alza Corporation Dosage form comprising fast agent delivery followed by slow agent delivery
US4816263A (en) * 1987-10-02 1989-03-28 Alza Corporation Dosage form for treating cardiovascular diseases comprising isradipine
ATE76292T1 (de) * 1987-11-25 1992-06-15 American Cyanamid Co System fuer die verzoegerte (kontrollierte) freisetzung von substituierten dihydropyridincalciumantagonisten.
US4837111A (en) * 1988-03-21 1989-06-06 Alza Corporation Dosage form for dispensing drug for human therapy
US4855141A (en) * 1988-03-25 1989-08-08 Alza Corporation Device comprising means for protecting and dispensing fluid sensitive medicament
US4859470A (en) * 1988-06-02 1989-08-22 Alza Corporation Dosage form for delivering diltiazem
US5612059A (en) * 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
IL91398A (en) * 1988-08-30 1994-05-30 Pfizer Pharmaceutical delivery device comprising active substance surrounded by asymmetric membrane
GR1000270B (el) * 1988-09-30 1992-05-12 Alza Corp Μορφη δοσολογιας για θεραπεια καρδιαγγειακων ασθενειων.
US5030452A (en) * 1989-01-12 1991-07-09 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
US5108756A (en) * 1989-01-12 1992-04-28 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
IL92966A (en) * 1989-01-12 1995-07-31 Pfizer Dispensing devices powered by hydrogel
EP0408496A3 (en) * 1989-07-12 1992-07-01 Ciba-Geigy Ag Solid dosage form for pharmaceutical substances
US5000962A (en) * 1989-08-25 1991-03-19 Schering Corporation Long acting diltiazem formulation
US4992277A (en) * 1989-08-25 1991-02-12 Schering Corporation Immediate release diltiazem formulation
US5067960A (en) * 1989-12-06 1991-11-26 Medtronic, Inc. Muscle fitness detection by colorimetry
US5190763A (en) * 1990-05-07 1993-03-02 Alza Corporation Dosage form indicated for the management of abnormal posture, tremor and involuntary movement
US5081161A (en) * 1990-06-15 1992-01-14 E. I. Du Pont De Nemours And Company Process for making shaped articles of a thermoplastic resin having a microcellular structure
NZ238867A (en) * 1990-07-12 1993-08-26 Alza Corp Dosage form for delayed release comprising pharmaceutically active substance and a drug-release hindering means and a second composition which imbibes fluid, expands, and ejects the active substance from the device
CA2087435C (en) * 1990-08-07 1998-05-05 Scott Max Herbig Use of interfacially-polymerized membranes in delivery devices
US5166145A (en) * 1990-09-10 1992-11-24 Alza Corporation Antiemetic therapy
JP2701977B2 (ja) * 1990-09-28 1998-01-21 ファイザー インク 疎水性媒体を含有する投薬体
US5208037A (en) * 1991-04-22 1993-05-04 Alza Corporation Dosage forms comprising polymers comprising different molecular weights
ES2158871T3 (es) * 1993-02-23 2001-09-16 Wolfgang Dr Werner Uso de una formulacion de calcio en un medicamento para la aplicacion terapeutica a vacas lecheras que sufren hipocalcemia.
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
US6287598B1 (en) * 1993-05-28 2001-09-11 Alza Corporation Method for providing sustained antiepileptic therapy
HU213407B (en) * 1993-12-09 1997-06-30 Egyt Gyogyszervegyeszeti Gyar Process for producing tablet with diffusive-osmotic release
US5460826A (en) * 1994-06-27 1995-10-24 Alza Corporation Morphine therapy
US5948787A (en) 1997-02-28 1999-09-07 Alza Corporation Compositions containing opiate analgesics
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
KR20030051760A (ko) * 2000-10-30 2003-06-25 유로-셀티크 소시에떼 아노뉨 서방성 하이드로코돈 제형
US20110104214A1 (en) 2004-04-15 2011-05-05 Purdue Pharma L.P. Once-a-day oxycodone formulations
DE10129725A1 (de) 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
DE10300111A1 (de) 2003-01-07 2004-07-15 Bayer Healthcare Ag Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
US10213387B2 (en) 2003-09-19 2019-02-26 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
US10226428B2 (en) 2003-09-19 2019-03-12 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
KR101164881B1 (ko) * 2003-09-19 2012-07-23 썬 파마슈티컬 인더스트리스 리미티드 경구용 약물 전달 시스템
DE10355461A1 (de) 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
EP1685841A1 (en) 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prevention and treatment of thromboembolic disorders
DE102005031577A1 (de) * 2005-07-06 2007-01-11 Bayer Healthcare Ag Pharmazeutische Darreichungsformen enthaltend eine Wirkstoffkombination von Nifedipin und/oder Nisoldipin und einem Angiotensin-II Antagonisten
DE102005045518A1 (de) 2005-09-23 2007-03-29 Bayer Healthcare Ag 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
DE102005047561A1 (de) 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
ATE502937T1 (de) 2005-10-04 2011-04-15 Bayer Schering Pharma Ag Neue polymorphe form von 5-chlor-n-(ä ( 5s )-2- 0x0-3-ä4-( 3-oxo-4-morpholinyl)-phenylü-1,3- oxazolidin-5-ylü -methyl)-2-thiophencarboxamid
DE102008059206A1 (de) 2008-11-27 2010-06-10 Bayer Schering Pharma Aktiengesellschaft Pharmazeutische Darreichungsform enthaltend Nifedipin oder Nisoldipin und einen Angiotensin-II Antagonisten und/oder ein Diuretikum
EP2437733A4 (en) * 2009-06-02 2014-01-08 Dow Global Technologies Llc RETARD-PHARMACEUTICAL FORM
DE102011007272A1 (de) 2011-04-13 2012-10-18 Bayer Pharma Aktiengesellschaft Verzweigte 3-Phenylpropionsäure-Derivate und ihre Verwendung
BR112014027618A2 (pt) 2012-05-07 2017-06-27 Bayer Pharma AG processo para a fabricação de uma forma de dosagem farmacêutica compreendendo nifedipina e candesartan cilexetil
UY34856A (es) 2012-07-03 2013-12-31 Bayer Pharma AG Formas de presentación farmacéuticas que contienen 5-cloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4- morfolinil)-fenil]-1,3-oxazolidin-5-il}-metil)-2-tiofencarboxamida
JP5941117B2 (ja) * 2014-10-17 2016-06-29 ダウ グローバル テクノロジーズ エルエルシー 徐放製剤
WO2020020790A1 (de) 2018-07-24 2020-01-30 Bayer Aktiengesellschaft Oral applizierbare pharmazeutische darreichungsform mit modifizierter freisetzung
US10905667B2 (en) 2018-07-24 2021-02-02 Bayer Pharma Aktiengesellschaft Orally administrable modified-release pharmaceutical dosage form
JP2021532113A (ja) 2018-07-24 2021-11-25 バイエル・アクチエンゲゼルシヤフト 経口投与可能であり、放出を修飾した薬学的投薬形態

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE376851B (enrdf_load_stackoverflow) * 1971-01-13 1975-06-16 Alza Corp
US3977404A (en) * 1975-09-08 1976-08-31 Alza Corporation Osmotic device having microporous reservoir
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4160452A (en) * 1977-04-07 1979-07-10 Alza Corporation Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina
US4200098A (en) * 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent
US4265874A (en) * 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4449983A (en) * 1982-03-22 1984-05-22 Alza Corporation Simultaneous delivery of two drugs from unit delivery device

Also Published As

Publication number Publication date
JPH0575725B2 (enrdf_load_stackoverflow) 1993-10-21
SE8402512L (sv) 1984-11-12
IE56515B1 (en) 1991-08-28
IE840010L (en) 1984-11-11
ZA842422B (en) 1984-11-28
CH669329A5 (enrdf_load_stackoverflow) 1989-03-15
NO840248L (no) 1984-11-12
JPS6041609A (ja) 1985-03-05
DE3417113C2 (enrdf_load_stackoverflow) 1989-02-02
AU566110B2 (en) 1987-10-08
IL71727A0 (en) 1984-09-30
AU2251183A (en) 1984-11-15
CA1222950A (en) 1987-06-16
NZ206600A (en) 1987-01-23
ES8503503A1 (es) 1985-03-01
SE455918B (sv) 1988-08-22
NL192250B (nl) 1996-12-02
DK99784D0 (da) 1984-02-24
DE3417113A1 (de) 1984-11-15
GB2140687A (en) 1984-12-05
AT397180B (de) 1994-02-25
GB8334189D0 (en) 1984-02-01
IT8467283A1 (it) 1985-09-23
MX163518B (es) 1992-05-25
NL8401470A (nl) 1984-12-03
NO170834C (no) 1992-12-16
DK99784A (da) 1984-11-12
NO170834B (no) 1992-09-07
IT8467283A0 (it) 1984-03-23
FR2545721A1 (fr) 1984-11-16
BE898819A (fr) 1984-05-30
IL71727A (en) 1989-01-31
DK163910C (da) 1992-09-14
NL192250C (nl) 1997-04-03
FR2545721B1 (fr) 1987-11-06
GB2140687B (en) 1987-03-18
ATA88084A (de) 1993-07-15
ES532018A0 (es) 1985-03-01
SE8402512D0 (sv) 1984-05-09
DK163910B (da) 1992-04-21

Similar Documents

Publication Publication Date Title
IT1178911B (it) Dispositivo osmotico avente duplice attivita termodinamica per la erogazione a velocita controllata di una sostanza particolarmente un farmaco all ambiente a cui e destinata
IT8322832A0 (it) Dispositivo per la somministrazione controllata di farmaci.
ES549639A0 (es) Dispositivo osmotico para la administracion controlada de unagente benefico a un ambiente de utilizacion
ES537022A0 (es) Un procedimiento para la preparacion de una formulacion medicamentosa para inyeccion intravenosa.
IT8267184A0 (it) Bendaggio per la somministrazione di medicamenti
IT1188095B (it) Dispositivo osmotico comprendente mezzi per regolare la durata iniziale di erogazione di un agente medicinali da detto dispositivo
DK253988A (da) Farmaceutisk praeparat med indhold af eperison eller tolperison, eller et salt deraf, til indgivelse gennem huden
NL195004B (nl) Fenylcarbamaat bevattend farmaceutisch preparaat.
DE68914344D1 (de) Immununterdrückende Verbindungen.
FI822943A7 (fi) Tromboksaanisyntetaasi-estoaineita, menetelmiä niiden valmistamiseksi sekä niitä sisältäviä farmaseuttisiayhdistelmiä.
DE3685170D1 (de) Histaminderivate enthaltende pharmazeutische zusammensetzung.
DE3480599D1 (de) 1-hydroxypyrid-2-on-derivate enthaltende pharmazeutische zubereitungen.
ES552145A0 (es) Procedimiento de fabricacion de una unidad de dosificacion para la administracion oral de cloruro potasico.
DK166479C (da) Anvendelse af fluoxetin, norfluoxetin eller et farmaceutisk acceptabelt salt af fluoxetin eller norfluoxetin til fremstilling af et laegemiddel med anxiolytisk virkning
IT1190824B (it) Composizione farmaceutica contenente 24,25-diidrossicolecalciferolo come ingrediente attivo
IT8319857A0 (it) Agenti antiflogistici/antipiretici/analgesici contenenti derivati di teobromina o teofillina come ingrediente attivo.
NO881558D0 (no) Oppvarmer for vaeske som stroemmer som fallende film.
IT1170728B (it) Dispositivo per la somministrazione di sostanze medicamentose
IT1179843B (it) Dispositivo osmotico e procedimento per l erogazione di un agente benefico particolarmente di un farmaco ad un ambiente d uso
IT1213080B (it) Sistemi terapeutico per la cessione controllata di farmaci.
IT8421874A0 (it) Forma farmaceutica solida orale ad azione sequenziale per la somministrazione di farmaci ad effetto collaterale ulcerogeno.
IT7822316A0 (it) Composizione farmaceutica per la somministrazione di pancreatina.
DK162631C (da) Forbindelse, betegnet fr-900216, til anvendelse som terapeutisk aktivt stof, farmaceutisk praeparat indeholdende forbindelsen samt anvendelse af forbindelsen
IT8149298A0 (it) Tampone per la somministrazione di nitroglicerina attraverso la pelle
FI823470A0 (fi) Nya cykliska iminer, deras tillverkning och farmaceutiska kompositioner innehaollande dessa

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19980327